Maier Lorizate

Title: Maier Lorizate: Innovator in HIV Research

Introduction

Maier Lorizate is a notable inventor based in Portugalete, Spain. He has made significant contributions to the field of virology, particularly in the context of HIV research. His innovative approach focuses on preventing viral entry into cells, which is crucial for developing effective treatments and vaccines.

Latest Patents

Lorizate holds a patent for a method aimed at blocking HIV entry into dendritic cells. The patent, titled "Method for blocking HIV entry into dendritic cells by inhibiting sialoadhesin-sialyllactose binding interactions with gangliosides," describes techniques to prevent viral entry by inhibiting the coupling of sialyllactose molecules in the viral membrane to the CD169/sialoadhesin receptor. This invention also includes vaccine compositions that utilize dendritic cells loaded with specific antigens, combined with compositions that prevent viral entry. Additionally, it relates to diagnostic and therapeutic compositions that can be specifically delivered to enveloped virions.

Career Highlights

Throughout his career, Lorizate has worked with prominent organizations, including Laboratorios del Dr. Esteve S.A. and Fundació Privada Institut de Recerca de la Sida—Caixa. His work has been instrumental in advancing research in the field of HIV and developing potential therapeutic solutions.

Collaborations

Lorizate has collaborated with notable colleagues, including Nuria Izquierdo Useros and Hans-Georg Krauesslich. These collaborations have further enriched his research and contributed to the scientific community's understanding of HIV.

Conclusion

Maier Lorizate's innovative work in HIV research exemplifies the importance of scientific advancements in combating viral infections. His contributions through patents and collaborations highlight the ongoing efforts to develop effective treatments and vaccines against HIV.